EyePoint Pharmaceuticals Appoints Isabelle Lefebvre as Chief Regulatory Officer

EyePoint Pharmaceuticals announced the appointment of Isabelle Lefebvre as Chief Regulatory Officer. Ms. Lefebvre brings more than 30 years of global regulatory affairs experience across all phases of drug development, including ophthalmic and ocular conditions. Ms. Lefebvre is succeeding John Weet, PhD, who be leaving his role as Senior Vice President, Regulatory, following a transition period.

“Isabelle brings a wealth of regulatory strategy experience from large and midsize global pharmaceutical companies along with a strong track record of leading successful drug approvals in the ocular space, and we are delighted to welcome her to our executive leadership team,” Nancy Lurker, Chief Executive Officer of EyePoint Pharmaceuticals, said in a companynews release. “In particular her ophthalmic and ocular expertise will be highly valuable as we progress our retina focused pipeline to bring our innovative products to patients in the United States and around the world. I also want to express my sincere gratitude to Dr. Weet for his many years of service to EyePoint, and for his important impact and leadership in building our regulatory infrastructure and contributing to the many successes of our products and pipeline.”

Prior to joining EyePoint, Ms. Lefebvre was Vice-President, Head of Regulatory Science at Hengrui USA where she was responsible for overseeing US and EU regulatory strategies for clinical programs in various phases of development. Previously, she spent 10 years at Bausch Health Companies where she held roles of increasing responsibility and led the successful approvals of two ocular drug products, Lotemax gel and Vyzulta. Earlier in her career, Ms. Lefebvre held senior roles in regulatory strategy and affairs at Lundbeck Inc., Alpharma Pharmaceuticals, Bristol-Myers Squibb, and Societe D’Analyses Biopharmaceutiques Inc. Ms. Lefebvre holds a B.S. in Biochemistry from the University of Montreal and an M.S. in Regulatory Affairs from Northeastern University.